Independent Advisor Alliance’s ADMA Biologics ADMA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.1M | Buy |
115,563
+26,088
| +29% | +$475K | 0.06% | 265 |
|
|
2025
Q1 | $1.78M | Buy |
+89,475
| New | +$1.78M | 0.06% | 270 |
|
|
2023
Q2 | – | Sell |
-10,193
| Closed | -$33.7K | – | 669 |
|
|
2023
Q1 | $33.7K | Hold |
10,193
| – | – | ﹤0.01% | 650 |
|
|
2022
Q4 | $40 | Hold |
10,193
| – | – | ﹤0.01% | 404 |
|
|
2022
Q3 | $25K | Hold |
10,193
| – | – | ﹤0.01% | 616 |
|
|
2022
Q2 | $20K | Hold |
10,193
| – | – | ﹤0.01% | 609 |
|
|
2022
Q1 | $19K | Hold |
10,193
| – | – | ﹤0.01% | 654 |
|
|
2021
Q4 | $14K | Hold |
10,193
| – | – | ﹤0.01% | 669 |
|
|
2021
Q3 | $12K | Buy |
+10,193
| New | +$12K | ﹤0.01% | 629 |
|
|
2021
Q1 | – | Sell |
-10,193
| Closed | -$20K | – | 590 |
|
|
2020
Q4 | $20K | Buy |
+10,193
| New | +$20K | ﹤0.01% | 538 |
|